ResearcherZhongnan Hospital of Wuhan UniversityActive in the last 2 years
Hengning Ke
Matched on ORCID iD 0000-0002-6091-3392; OpenAlex author ID A5102795819.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 2 (first author 0, last author 1)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Collaborators
- 3
2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 2
- Guanylate-binding protein 2 (GBP2) drives pancreatic cancer cell proliferation by promoting cell cycle progression via the SP1/SKP2/P27 axis. Co-author DOI 10.1186/s12967-026-08815-6↗
- A Novel Ferroptosis-Related lncRNAs Signature Predicts Clinical Prognosis and Is Associated With Immune Landscape in Pancreatic Cancer. Last author DOI 10.3389/fgene.2022.786689↗
Closest collaborators
The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Haizhou Wang · 1 shared paper, 2026
- Shilin Fang · 1 shared paper, 2026
- Haiqin Ping · 1 shared paper, 2022
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.